Select basic information for advanced search
| Free word |
|---|
| Copy service |  |
|---|---|
| Related links |  |
| Publisher site |  |
Safety and Effectiveness of Natalizumab Post-Marketing Surveillance: The 3rd Year Interim Results
About YOKOYAMA Kazumasa
About 順天堂大 医 脳神経内科
About SATO Ryusuke
About バイオジェン・ジャパン
About MAKIOKA Daiki
About バイオジェン・ジャパン
About IIZUKA Yukihiko
About バイオジェン・ジャパン
About HIRAMATSU Katsutoshi
About バイオジェン・ジャパン
About LING Yan
About バイオジェン・ジャパン
About TORII Shinichi
About バイオジェン・ジャパン
About SAITA Takahiko
About 関西多発性硬化症セ
About SAITA Takahiko
About 京都保健会 京都民医連中央病院
Material：
About Neuroimmunology
Volume： 23 Issue： 1 Page： 132 Publication year： 2018
JST Material Number： L3036C ISSN： 0918-936X Document type： Proceedings
Article type： 会議録記事 Country of issue： Japan (JPN) Language： ENGLISH (EN)
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
About human
Semi thesaurus term：
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
About natalizumab
Please login to MyJ-GLOBAL to see full information. You also need to select "Display abstract, etc. of medical articles" in your MyJ-GLOBAL account page in order to see abstracts, etc. of medical articles.
Category name(code) classified by JST.
About Drug therapy(=pharmacotherapy)for nervous system diseases
About Treatment for immunologic diseases,allergic diseases.
Keywords automatically extracted from the title.
About ナタリズマブ
About 安全性
About 市販後調査
Return to Previous Page
